Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long SNPS Daily ETF

24.55
0.0000
Volume:- -
Turnover:- -
Market Cap:1.47M
PE:- -
High:24.55
Open:24.55
Low:24.55
Close:24.55
52wk High:43.54
52wk Low:20.60
Shares:60.00K
Float Shares:60.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Tradr 2X Long SNPS Daily ETF
Exchange:
CBOE
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Synaptogenix, Inc. operates as a biopharmaceutical company. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and niemann-pick type C disease. It has licensing agreements with Stanford University; Icahn School of Medicine; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is based in New York, New York.